Showing results (41-50 of 177) with videos related to
Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study GroupR Arriagada, T Le Chevalier, P Ruffié, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approachF Rotolo, A Dunant, T Le Chevalier, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trialA Rivière, A Le Cesne, J Berille, et al.Bulletin Du Cancer|December 10, 1999
[Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer]F André, W Jacot, J L Pujol, et al.Bulletin De L'Academie Nationale De Medecine|November 1, 1991
[Chemotherapy of soft tissue sarcoma in adults]J Rouëssé, M Spielmann, T Le Chevalier, et al.The Annals of Thoracic Surgery|February 4, 1999
Pneumonectomy for lung metastases: indications, risks, and outcomeL Spaggiari, D H Grunenwald, P Girard, et al.Investigational New Drugs|November 1, 1992
Phase II study of a combination of elliptinium and vinblastine in metastatic breast cancerL Kayitalire, F Thomas, T Le Chevalier, et al.Chest|November 1, 1994
Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancerJ L Pujol, M Hayot, P Rouanet, et al.Critical Reviews in Oncology/Hematology|February 19, 2005
Molecular prognostic factors in resectable non-small cell lung cancerP Vielh, J-P Spano, J Grenier, et al.La Nouvelle Presse Medicale|March 20, 1982
[Surgical treatment of pulmonary metastases in adult patients (author's transl)]T Le Chevalier, J Rouësse, G Lemoine, et al.Pageof 18